Abstract
Background: The co morbidity of substance abuse and schizophrenia is very high and apart from its etiological influence, this affects phenomenology, course and outcome of each other. These can includes onset, course, and association of mood, hostility, anxiety, and severity of symptoms, relapses, and frequent hospitalizations, non- compliance to treatment and poorer psychosocial functioning. Methods: The literature (Medline, Psycinfo, Scopus, and Cochrane Database of Systematic Reviews, Google scholar, Index Copernicus International and Pro Quest medical databases) on comorbid substance use and schizophrenia was reviewed. Results: This review presents recent understanding of this co morbidity, addressing substance use as risk factor and impact on onset for schizophrenia and its early influence over positive, negative or cognitive symptoms dimensions. Individual class of substance of abuse and various other influential factors such as duration of untreated psychosis, treatment course and mortality are related directly or indirectly. Conclusion: Overall the co-morbidity of substance abuse and schizophrenia causes diagnostic instability, resulting in poor functional outcome; thus needs better awareness and understandings for its prevention, assessment and treatment.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
